Form 4 for ANIX Anixa Biosciences Inc
Accepted 2022-05-02 00:00:00 ET · period of report 2022-04-29 · accession 0001493152-22-011741 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-02 | 2022-04-29 | ANIX | Catelani Michael | Pres | J - Other | $2.76 | +1,086 | 19.2K | +6% | +$2,997 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-29 | J | A | 1,086 | $2.76 | 19,221 | D | — | — | (F2) In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on April 29, 2022. |